Kufstein, Austria

Kurt Riedl

This inventor holds 1 USPTO granted patent. Top assignee: Biochemie Gmbh. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kurt Riedl. Retrieved from https://idiyas.com/inventor/kurt-riedl-djgi5g7v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kurt Riedl - Innovator in Pharmaceutical Production

Introduction

Kurt Riedl is a notable inventor based in Kufstein, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the production of penicillins. His innovative methods have the potential to enhance the efficiency and effectiveness of antibiotic production.

Latest Patents

Kurt Riedl holds a patent for a novel process for the production of penicillins. This invention provides a new method for producing phenylglycyl chloride hydrochlorides. The process involves the reaction of N-substituted phenylglycines with thionyl chloride and gaseous hydrogen chloride. Additionally, it introduces certain novel starting materials and end-products that are beneficial in this production process.

Career Highlights

Kurt Riedl is associated with Biochemie GmbH, where he applies his expertise in pharmaceutical development. His work has contributed to advancements in the production of essential medications, showcasing his commitment to improving healthcare through innovation.

Collaborations

Kurt Riedl collaborates with Gerd Ascher, working together to further their research and development efforts in the pharmaceutical industry.

Conclusion

Kurt Riedl's contributions to the field of pharmaceuticals, particularly through his innovative patent, highlight his role as a key inventor in the industry. His work continues to influence the production of vital medications, underscoring the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…